Skip to main content
. 1999 Sep 18;319(7212):731–734. doi: 10.1136/bmj.319.7212.731

Table 1.

Effect of decision aids on patient’s knowledge of options and outcomes

Decision Decision aid
Comparison group
Weight Mean difference (95% CI)
No of patients Mean (SD) knowledge score No of patients Mean (SD) knowledge score
Compared with usual care
Benign prostate disease15 104 75 (45) 123 54 (45) 14.1 21 (9 to 33)
Ischaemic heart disease25 86 75 (17) 94 62 (17) 29.4 13 (8 to 18)
Ischaemic heart disease16 61 83 (16) 48 58 (16) 26.4 25 (19 to 31)
BRCA1 gene test22 122 69 (19) 164   49 (21.7) 30.1 20 (15 to 25)
Total (random effects χ2=9.6 (df =3), Z=6.85) 373 429 100 19 (14 to 25)
Compared with less intensive decision aid
Hormone therapy28 83 87 (11) 87 84 (12) 47.4 3 (−0.4 to 6)
Hormone therapy26 81 75 (20) 84 71 (21) 14.3 4 (−2 to 10)
Prenatal screen24 67 88 (15) 88 87 (16) 24.7 0.9 (−4 to 6)
Mastectomy29 30 83 (12) 30 76 (14) 13.5  6 (−0.3 to 13)
Total (fixed effects χ2=1.8 (df =3), Z=2.54) 261 289 100 3 (0.7 to 5)  

Knowledge tests regarding options and outcomes were specific to the decision and were scored from 0 (0% items correct) to 100 (100% items correct). 

HHS Vulnerability Disclosure